K. Matsui, A. Kashima, and A. Motegi, “Norfloxacin, a Fluoroquinolone Antibiotic, Inhibits Langerhans Cell-Mediated Th1 and Th2 Cell Development”, J Pharm Pharm Sci, vol. 22, no. 1, pp. 122–130, Apr. 2019.